Bayer CropScience Faces Rs. 37.41 Million GST Penalty from Central Tax Authority

1 min read     Updated on 22 Oct 2025, 03:19 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Bayer Crop Science has been issued a penalty order of Rs. 37.41 million by the Office of the Commissioner of Central Tax, Guntur, Andhra Pradesh. The penalty is related to GST on Outward Supply for the Financial Year 2018-19. The company received the order on October 21, 2025, and is considering appealing against it. This disclosure was made in compliance with SEBI regulations.

22672183

*this image is generated using AI for illustrative purposes only.

Bayer Crop Science has received a penalty order of Rs. 37.41 million from the Office of the Commissioner of Central Tax, Guntur, Andhra Pradesh. The penalty relates to Goods and Services Tax (GST) on Outward Supply for the Financial Year 2018-19.

Penalty Details

The company disclosed the following information regarding the penalty:

Aspect Details
Issuing Authority Office of the Commissioner of Central Tax, Guntur, Andhra Pradesh
Nature of Order Penalty related to GST on Outward Supply
Financial Year 2018-19
Penalty Amount Rs. 37.41 Million
Date of Order Receipt October 21, 2025

Company's Response

Bayer Crop Science has stated that the order is currently appealable. The company plans to assess exercising its right to appeal against the penalty. This approach suggests that Bayer Crop Science may challenge the order if they believe there are grounds for contesting the penalty.

Regulatory Compliance

The company made this disclosure in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. This regulation mandates listed entities to inform stock exchanges about material events or information.

Potential Impact

While the penalty amount of Rs. 37.41 million is significant, the full financial impact on Bayer Crop Science will depend on the outcome of any potential appeal process. Shareholders and investors will likely be watching closely for further updates on this matter.

Historical Stock Returns for Bayer Crop Science

1 Day5 Days1 Month6 Months1 Year5 Years
-1.92%-2.90%-1.41%+1.83%-24.99%-9.58%
Bayer Crop Science
View in Depthredirect
like18
dislike

Bayer CropScience CEO Cautious on FY26 Outlook Despite India's Agricultural Potential

1 min read     Updated on 03 Sept 2025, 12:19 PM
scanx
Reviewed by
Suketu GalaScanX News Team
Overview

Bayer CropScience CEO Simon-Thorsten Wiebusch expressed measured optimism for the company's fiscal year 2026 outlook, balancing erratic monsoons against India's untapped agricultural market potential. The year started strong, but inconsistent rainfall patterns have introduced uncertainty. September's weather is crucial for the kharif season, while the rabi season outlook is more positive due to well-filled dams and stable commodity prices. Wiebusch highlighted India's significant growth potential as an under-penetrated market. He noted that gross margin pressures, particularly related to glyphosate pricing, may be easing. However, external factors like industrial overcapacity in China could still impact the Indian market.

18427751

*this image is generated using AI for illustrative purposes only.

Bayer Crop Science CEO, Simon-Thorsten Wiebusch, has expressed measured optimism regarding the company's fiscal year 2026 outlook, balancing the challenges of erratic monsoons against India's untapped agricultural market potential.

Strong Start, Inconsistent Progress

The year began on a positive note for Bayer CropScience, with early monsoons boosting the company's first-quarter performance. However, Wiebusch noted that subsequent rainfall patterns have been inconsistent and erratic, introducing uncertainty into the agricultural sector's prospects.

Critical September for Kharif Season

Wiebusch emphasized the importance of September's weather conditions in determining the success of the kharif crop season. This period is crucial for many of India's important crops and could significantly impact the agricultural industry's performance.

Positive Outlook for Rabi Season

Despite the kharif season uncertainties, the CEO expressed a more optimistic view for the upcoming rabi season. Well-filled dams and stable commodity prices for farmers are expected to contribute positively to this winter crop season.

India's Untapped Agricultural Market

Highlighting India's growth potential, Wiebusch pointed out that the country remains an under-penetrated market compared to other nations. This presents significant opportunities for agricultural input companies like Bayer CropScience to expand their presence and offerings.

Evolving Industry Dynamics

The CEO cautioned that the agricultural sector is increasingly influenced by factors beyond traditional monsoon patterns. This evolving landscape requires companies to adapt their strategies and outlook continuously.

Gross Margin Pressures Easing

Addressing industry concerns about gross margin pressures, particularly related to glyphosate pricing, Wiebusch suggested that the worst may be over. He indicated that the company has likely reached the bottom in terms of gross margins on the chemical side of the business.

External Challenges Persist

While expressing cautious optimism, Wiebusch acknowledged that external factors, such as industrial overcapacity in China, could still impact the Indian market. This highlights the interconnected nature of global agricultural markets and the need for companies to remain vigilant to international trends.

As Bayer CropScience navigates these complex market conditions, stakeholders will be closely watching how the company capitalizes on India's agricultural potential while managing the challenges posed by climate variability and global market dynamics.

Historical Stock Returns for Bayer Crop Science

1 Day5 Days1 Month6 Months1 Year5 Years
-1.92%-2.90%-1.41%+1.83%-24.99%-9.58%
Bayer Crop Science
View in Depthredirect
like17
dislike
More News on Bayer Crop Science
Explore Other Articles
4,854.50
-94.80
(-1.92%)